Joan represents clients in complex civil litigation including product liability, class actions and mass and aggregated litigation. She defends clients in both federal and state courts as well as in MDLs and state-court-coordinated proceedings. Her experience includes successful representation through risk assessments, pre-litigation claim negotiation, managing discovery and related motion practice, drafting and arguing dispositive motions, taking and defending depositions, corporate and expert witness development, pretrial motion practice, settlement negotiations, trials and appeals. 

Joan has been an author and presenter on various aspects of class actions and product liability. She was the chair of the American Bar Association Tort, Trial and Insurance Practice Section’s Pharmaceutical, Medical Device and Bioscience Committee, which educates its members on legal issues relating to the life sciences including class action litigation.

In addition, Joan also dedicates time to pro bono work including civil rights and immigration.



Co-Presenter: What's on the Front Burner: Cutting Edge Issues in Class Actions, Mass Arbitrations & Opt-Out Litigation, Update of the Law CLE webinar, June 16, 2022 (with Michael Mallow, Amir Nassihi and Rachel Straus). 

Moderator, A View From the Bench: Judicial Insights on Managing Complex Litigation and the Pandemic’s Lasting Impact, ABA Motor Vehicle Product Liability Litigation Conference, Scottsdale, Arizona, April 8, 2022.

Moderator/Speaker: Recent Trends in Consumer Class Actions, Update of the Law CLE, Kansas City, Missouri, June 10, 2021.

Speaker: Key Decisions Affecting Drug and Device Litigation, ABA Pharmaceutical, Medical Device and Bioscience Conference Virtual Regional Program, San Francisco, California, February 26, 2021.

Panelist, Recent Decisions in Preemption, Innovatory Liability & Personal Jurisdiction, Update of the Law CLE, Kansas City, Missouri, June 12, 2020.

Moderator, Managing Mass Torts and Complex Civil Rights Cases, and Increasing Diversity in the Bar, ACBA Complex Litigation Symposium, November 7, 2019. 

Program Co-Chair, Current Issues in Pharmaceutical, Medical Device & Biotech Litigation Regional CLE Program, New York City, October 24-25, 2019. 

Panelist, Protecting Your Company's Brand: How to Minimize the Risk of a Consumer Class Action Lawsuit and Maximize the Chances of Winning if One is Filed, Association of Corporate Counsel, San Francisco and Palo Alto, California, December 4, 2017.

Speaker, The Bristol-Myers Squibb Decision & California Practice Pointers, PMDLD Attorney Summit, Kansas City, Missouri, October 5, 2017.

Panelist, Key Decisions: Preemption, Innovator Liability & Personal Jurisdiction, ABA Life Sciences Legal Summit, South San Francisco, California, September 14, 2017. 

Panelist, Give Me Your Money or Your Data! Minimizing the Legal and Operational Risks of Ransomware, Association of Corporate Counsel, Burlingame, California, June 8, 2017. 

Speaker, Amendments to the Federal Rules of Civil Procedure, CLE Presentation, San Francisco, California, December 16, 2015.


Joan R. Camagong, Editor, Ch. 14, Punitive Damages, California Tort Damages, 2nd Edition, Cal CEB, 2021.

Joan Camagong, Co-Author, California Tort Damages, 2nd Edition, Cal CEB, 2021 (with Amy Depuy, Pat Gregory and Matt Williams).

Joan R. Camagong, Personal Jurisdiction Over Unnamed Class Members, Products Liability Litigation Newsletter, American Bar Association, August 2019.

Joan R. Camagong, Applying Bristol-Myers Squibb to Class Actions, Products Liability Litigation Practice Points, American Bar Association, February 2019.

Joan R. Camagong, Recent Developments in Personal Jurisdiction, TortSource, Volume 21, American Bar Association: Tort Trial and Insurance Practice Section, Winter 2018.